VECT Key Statistics, Chart & Performance
The current stock price of VECT is 16.85 USD. In the past month the price increased by 1.08%. In the past year, price increased by 186.54%.
VECT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to VECT. When comparing the yearly performance of all stocks, VECT is one of the better performing stocks in the market, outperforming 98.97% of all stocks.
VECT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VECT. VECT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
VECT Financial Highlights
Over the last trailing twelve months VECT reported a non-GAAP Earnings per Share(EPS) of -1.87. The EPS increased by 22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.05 |
VECT Forecast & Estimates
8 analysts have analysed VECT and the average price target is 18.36 USD. This implies a price increase of 8.96% is expected in the next year compared to the current price of 16.85.
For the next year, analysts expect an EPS growth of 8.67% and a revenue growth -96.99% for VECT
VECT Ownership
VECT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.39 | 394.886B | ||
| AMGN | AMGEN INC | 17.06 | 206.949B | ||
| GILD | GILEAD SCIENCES INC | 17.1 | 189.204B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.44 | 121.258B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.91 | 82.557B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 48.99 | 43.353B | ||
| INSM | INSMED INC | N/A | 31.961B | ||
| BIIB | BIOGEN INC | 13.22 | 29.513B | ||
| NTRA | NATERA INC | N/A | 28.022B | ||
| INCY | INCYTE CORP | 13.54 | 21.279B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About VECT
Company Profile
VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. The company is headquartered in Basel, Basel-Stadt and currently employs 42 full-time employees. The company went IPO on 2021-04-09. The firm trough it's subsidiaries operates as a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe rare conditions for which there is a significant unmet medical need.
Company Info
VectivBio Holding AG
Aeschenvorstadt 36
Basel BASEL-STADT 22046 CH
Employees: 42
Phone: 41615513030.0
VectivBio Holding AG / VECT FAQ
Can you describe the business of VectivBio Holding AG?
VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. The company is headquartered in Basel, Basel-Stadt and currently employs 42 full-time employees. The company went IPO on 2021-04-09. The firm trough it's subsidiaries operates as a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe rare conditions for which there is a significant unmet medical need.
What is the current price of VECT stock?
The current stock price of VECT is 16.85 USD.
Does VECT stock pay dividends?
VECT does not pay a dividend.
What is the ChartMill technical and fundamental rating of VECT stock?
VECT has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting VECT stock to perform?
8 analysts have analysed VECT and the average price target is 18.36 USD. This implies a price increase of 8.96% is expected in the next year compared to the current price of 16.85.
Can you provide the PE ratio for VECT stock?
VectivBio Holding AG (VECT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.87).
What is the market capitalization of VECT stock?
VectivBio Holding AG (VECT) has a market capitalization of 1.06B USD. This makes VECT a Small Cap stock.